Showing 2751-2760 of 7016 results for "".
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
https://reachmd.com/clinical-practice/cardiology/scout-hcm-mavacamten-in-adolescents-with-symptomatic-obstructive-hypertrophic-cardiomyopathy/56460/Explore phase 3 SCOUT-HCM findings on mavacamten from ACC 2026, including study design, efficacy outcomes, and implications for managing adolescents with oHCM.Molecular Precision: How Myosin Inhibitors Redefine Control
https://reachmd.com/programs/cme/molecular-precision-how-myosin-inhibitors-redefine-control/54839/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
https://reachmd.com/programs/neurofrontiers/gfap-and-vegf-trajectories-in-adult-type-3-spinal-muscular-atrophy-under-nusinersen/54637/RAS Across Tumors: Who to Test When
https://reachmd.com/programs/cme/ras-across-tumors-who-to-test-when/54117/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Tracking Immune Activity in Severe Alopecia Areata
https://reachmd.com/programs/dermconsult/immune-activity-severe-alopecia-areata/49022/CKD-aP: Beyond the Surface
https://reachmd.com/programs/cme/ckd-ap-beyond-the-surface/36294/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.PCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
https://reachmd.com/programs/heart-matters/pcsk9-inhibitors-and-statins-meta-analysis-highlights-benefit-of-combination-therapy/37594/Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
https://reachmd.com/programs/neurofrontiers/Reevaluating-Natalizumab-Dosing-in-RRMS-Insights-from-the-NOVA-Trial/36359/Passion for Passing on Knowledge
https://reachmd.com/ma-issues-index/july-august-2025/sebastian-cotofana-facial-anatomy-education-platform-injector/36661/Renowned researcher gives back through online educationStaging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
https://reachmd.com/programs/heart-matters/staging-the-benefit-tafamidis-outcomes-in-attr-cm-depend-on-timing/36137/